Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice

Lucio Pastore, Ligia Belalcazar, Kazuhiro Oka, Racel Cela, Brendan Lee, Lawrence Chan, Arthur L. Beaudet

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Apolipoprotein A-I (APOA-I) is the major protein component of high-density lipoproteins (HDL). It has been shown that over-expression of human APOA-I increases HDL cholesterol and decreases atherosclerosis. We constructed a helper-dependent adenoviral (HD-Ad) vector that contains the entire human APOA-I gene (hgAI). Intravenous delivery of 1×1013 viral particles/kg of this vector was followed by high levels of human APOA-I expression (up to 200 mg/dl) in the absence of detectable hepatic toxicity. We treated apo E-deficient mice with the hgAI vector and fed them either with a high-fat diet or with regular chow. As a control, two groups of mice were treated with PBS. The apo E-deficient mice treated with the hgAI vector showed supraphysiological levels of expression of human APOA-I at week 4 and high levels of HDL cholesterol compared to the control groups. Analysis of aortic atherosclerotic lesions 20 weeks after treatment, showed a significant reduction of lesion size in the treated mice with both diets. In conclusion, liver-directed gene transfer of human APOA-I using a HD-Ad vector resulted in a reduction of the development of atherosclerosis with the absence of significant toxicity.

Original languageEnglish (US)
Pages (from-to)153-160
Number of pages8
JournalGene
Volume327
Issue number2
DOIs
StatePublished - Mar 3 2004

Fingerprint

Apolipoproteins E
Atherosclerosis
HDL Cholesterol
Control Groups
Liver
Apolipoprotein A-I
High Fat Diet
HDL Lipoproteins
Virion
Genes
human APOA1 protein
Diet
Proteins

Keywords

  • Apo A-I
  • Helper-dependent adenovirus
  • High-density lipoproteins

ASJC Scopus subject areas

  • Genetics

Cite this

Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. / Pastore, Lucio; Belalcazar, Ligia; Oka, Kazuhiro; Cela, Racel; Lee, Brendan; Chan, Lawrence; Beaudet, Arthur L.

In: Gene, Vol. 327, No. 2, 03.03.2004, p. 153-160.

Research output: Contribution to journalArticle

Pastore, Lucio ; Belalcazar, Ligia ; Oka, Kazuhiro ; Cela, Racel ; Lee, Brendan ; Chan, Lawrence ; Beaudet, Arthur L. / Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. In: Gene. 2004 ; Vol. 327, No. 2. pp. 153-160.
@article{0a97240f24e140c38c20350a088b64e1,
title = "Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice",
abstract = "Apolipoprotein A-I (APOA-I) is the major protein component of high-density lipoproteins (HDL). It has been shown that over-expression of human APOA-I increases HDL cholesterol and decreases atherosclerosis. We constructed a helper-dependent adenoviral (HD-Ad) vector that contains the entire human APOA-I gene (hgAI). Intravenous delivery of 1×1013 viral particles/kg of this vector was followed by high levels of human APOA-I expression (up to 200 mg/dl) in the absence of detectable hepatic toxicity. We treated apo E-deficient mice with the hgAI vector and fed them either with a high-fat diet or with regular chow. As a control, two groups of mice were treated with PBS. The apo E-deficient mice treated with the hgAI vector showed supraphysiological levels of expression of human APOA-I at week 4 and high levels of HDL cholesterol compared to the control groups. Analysis of aortic atherosclerotic lesions 20 weeks after treatment, showed a significant reduction of lesion size in the treated mice with both diets. In conclusion, liver-directed gene transfer of human APOA-I using a HD-Ad vector resulted in a reduction of the development of atherosclerosis with the absence of significant toxicity.",
keywords = "Apo A-I, Helper-dependent adenovirus, High-density lipoproteins",
author = "Lucio Pastore and Ligia Belalcazar and Kazuhiro Oka and Racel Cela and Brendan Lee and Lawrence Chan and Beaudet, {Arthur L.}",
year = "2004",
month = "3",
day = "3",
doi = "10.1016/j.gene.2003.11.024",
language = "English (US)",
volume = "327",
pages = "153--160",
journal = "Gene",
issn = "0378-1119",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice

AU - Pastore, Lucio

AU - Belalcazar, Ligia

AU - Oka, Kazuhiro

AU - Cela, Racel

AU - Lee, Brendan

AU - Chan, Lawrence

AU - Beaudet, Arthur L.

PY - 2004/3/3

Y1 - 2004/3/3

N2 - Apolipoprotein A-I (APOA-I) is the major protein component of high-density lipoproteins (HDL). It has been shown that over-expression of human APOA-I increases HDL cholesterol and decreases atherosclerosis. We constructed a helper-dependent adenoviral (HD-Ad) vector that contains the entire human APOA-I gene (hgAI). Intravenous delivery of 1×1013 viral particles/kg of this vector was followed by high levels of human APOA-I expression (up to 200 mg/dl) in the absence of detectable hepatic toxicity. We treated apo E-deficient mice with the hgAI vector and fed them either with a high-fat diet or with regular chow. As a control, two groups of mice were treated with PBS. The apo E-deficient mice treated with the hgAI vector showed supraphysiological levels of expression of human APOA-I at week 4 and high levels of HDL cholesterol compared to the control groups. Analysis of aortic atherosclerotic lesions 20 weeks after treatment, showed a significant reduction of lesion size in the treated mice with both diets. In conclusion, liver-directed gene transfer of human APOA-I using a HD-Ad vector resulted in a reduction of the development of atherosclerosis with the absence of significant toxicity.

AB - Apolipoprotein A-I (APOA-I) is the major protein component of high-density lipoproteins (HDL). It has been shown that over-expression of human APOA-I increases HDL cholesterol and decreases atherosclerosis. We constructed a helper-dependent adenoviral (HD-Ad) vector that contains the entire human APOA-I gene (hgAI). Intravenous delivery of 1×1013 viral particles/kg of this vector was followed by high levels of human APOA-I expression (up to 200 mg/dl) in the absence of detectable hepatic toxicity. We treated apo E-deficient mice with the hgAI vector and fed them either with a high-fat diet or with regular chow. As a control, two groups of mice were treated with PBS. The apo E-deficient mice treated with the hgAI vector showed supraphysiological levels of expression of human APOA-I at week 4 and high levels of HDL cholesterol compared to the control groups. Analysis of aortic atherosclerotic lesions 20 weeks after treatment, showed a significant reduction of lesion size in the treated mice with both diets. In conclusion, liver-directed gene transfer of human APOA-I using a HD-Ad vector resulted in a reduction of the development of atherosclerosis with the absence of significant toxicity.

KW - Apo A-I

KW - Helper-dependent adenovirus

KW - High-density lipoproteins

UR - http://www.scopus.com/inward/record.url?scp=1242338802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242338802&partnerID=8YFLogxK

U2 - 10.1016/j.gene.2003.11.024

DO - 10.1016/j.gene.2003.11.024

M3 - Article

VL - 327

SP - 153

EP - 160

JO - Gene

JF - Gene

SN - 0378-1119

IS - 2

ER -